Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

ClinicalTrials.gov ID: NCT00616902

Public ClinicalTrials.gov record NCT00616902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Study Protocol M10-221 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effects of paricalcitol injection on cardiac structure and function over 48 weeks in subjects with Stage 5 Chronic Kidney Disease (CKD) receiving hemodialysis who have left ventricular hypertrophy (LVH).

Study identification

NCT ID
NCT00616902
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
12 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2009 (Type not available)
Primary completion
May 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Jan 20, 2012

2009

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Arizona Kidney Disease & Hypertension Center Phoenix Arizona 85027 —
Southwest Kidney Institute Tempe Arizona 85284 —
National Institute of Clinical Research Bakersfield California 93309 —
National Institute of Clinical Research Los Angeles California 90017 —
University of Southern California Kidney Center Los Angeles California 90033 —
North American Research Institute - California Kidney Specialist San Dimas California 91773 —
Kidney Center of Simi Valley Simi Valley California 93065 —
Western Nephrology and Metabolic bone disease Arvada Colorado 80002 —
Western Nephrology Westminster Colorado 80031 —
Washington Nephrology Associates, LLP Washington D.C. District of Columbia 20017 —
Fresenius Dialysis - Carrollwood Tampa Florida 33624 —
FMC-NA Central Atlanta Atlanta Georgia 30329 —
University of Illinois at Chicago - Nephrology Research Chicago Illinois 60612 —
The University of Chicago - Stony Island Dialysis Unit Chicago Illinois 60617 —
Evanston Northwestern Healthcare Corp. - Division of Nephrology Evanston Illinois 60201 —
Research By Design, LLC Evergreen Park Illinois 60805 —
North Suburban Nephrology Gurnee Illinois 60031 —
Biolab Research LLC Rockville Maryland 20852 —
Fresenius Medical Care Kalamazoo Michigan 49007 —
V.A. Medical Center Research Kansas City Missouri 64128 —
Washington University School of Medicine - Division of Renal Disease St Louis Missouri 63110 —
Creighton University Medical Center Omaha Nebraska 68131 —
Brookdale Physicians Dialysis Associates Brooklyn New York 11212 —
Nephrology Associates, PLLC Winston-Salem North Carolina 27103-7108 —
MetroHealth Medical Center Cleveland Ohio 44109 —
G. Edward Newman, MD, LLC Knoxville Tennessee 37923 —
V.A. Tennessee Valley Healthcare System Nashville Tennessee 37212 —
Southwest Houston Research, Ltd Houston Texas 77099 —
The University of Texas - Health Science Center at San Antonio San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00616902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 20, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00616902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →